biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > JD still can't admit it

<< Previous

Bullboard Posts

Next >>

Post by zwerp2000on Nov 10, 2023 3:36pm

185 Views

Post# 35729227

JD still can't admit it

15+ years of his life spent on this board, doing DD on the company etc and for what? he was wrong the entire time. and not just a little wrong.......all wrong. you can't get any more wrong than he got it. how could he be so off on his DD? what a waste of time and a life and nothing to show for it. humiliating to say the least. in the end, the stock and technology is worth nothing and JD is viewed by all as a laughable joke.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments